NMTC
insider transactionsNEUROONE MEDICAL TECHNOLOGIES Corp — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-15.4K
0 buy · 15.4K sell
Net value · 90d
-$11.4K
$0 in · $11.4K out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
1
0 buy · 15.4K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
26.0K sh
Own New
-
Grant·A
Director
$0
41.9K sh
Own +540%
-
Grant·A
Director
$0
26.0K sh
Own New
-
Grant·A
Director
$0
41.9K sh
Own +37%
-
Grant·A
Director
$0
26.0K sh
Own New
-
Grant·A
Director
$0
41.9K sh
Own +46%
-
Other·F
David A Rosa KEY
CEO and President
$1.9K
2.5K sh · $0.78
Own -0%
-
Other·F
Chief Technology Officer
$704
906 sh · $0.78
Own -1%
-
Other·F
Business Development Director
$197
253 sh · $0.78
Own -0%
-
Sell·S
Business Development Director
$11.4K
15.4K sh · $0.74
Own -7%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Apr 3, 2026 | Jason Richard Mills | Grant A | 26.0K | $0 |
| Apr 3, 2026 | Jason Richard Mills | Grant A | 41.9K | $0 |
| Apr 3, 2026 | Jeffrey S Mathiesen | Grant A | 26.0K | $0 |
| Apr 3, 2026 | Jeffrey S Mathiesen | Grant A | 41.9K | $0 |
| Apr 3, 2026 | Edward Andrle | Grant A | 26.0K | $0 |
| Apr 3, 2026 | Edward Andrle | Grant A | 41.9K | $0 |
| Mar 31, 2026 | David A Rosa KEY | Other F | 2.5K | $1.9K |
| Mar 31, 2026 | Steve Mertens | Other F | 906 | $704 |
| Mar 31, 2026 | Mark Christianson | Other F | 253 | $197 |
| Mar 30, 2026 | Mark Christianson | Sell S | 15.4K | $11.4K |
About NMTC insider trading
This page tracks insider transactions for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.